Health In Tech to Host Annual Meeting of Stockholders
STUART, Fla., Sept. 11, 2025 /PRNewswire/ -- Health In Tech (Nasdaq: HIT) will host its 2025 Annual Stockholder Meeting on Friday, October 3, 2025, at 10:00 AM ET live via virtual webcast. To participate in the Annual Stockholders Meeting, stockholders should visit www.cleartrustonline.com/HIT or the Company's Investor Relations site at https://healthintech.investorroom.com/ under...
TVM Capital Healthcare Announces First Closing of its USD 150 Million Southeast Asia Fund
SINGAPORE, Sept. 11, 2025 /PRNewswire/ -- TVM Capital Healthcare, a global private equity investor and operator specialized in healthcare growth capital across emerging markets, today announced the first closing of its USD 150 million TVM Healthcare Southeast Asia Fund ("SEA Fund"). The SEA Fund is the third generation of TVM Capital Healthcare funds and...
Mars Snacking and Unreasonable Group Welcome Fourteen New Ventures to Unreasonable Food™
As an international network, Unreasonable Food is uniquely positioned to scale high-growth ventures dedicated to creating a more sustainable food system. NEW YORK, Sept. 11, 2025 /PRNewswire/ -- Today, as part of the Unreasonable Food™ collaboration, Mars and Unreasonable Group are welcoming the next generation of growth stage ventures into the Unreasonable Food...
Three global institutions win million dollar prize for the 2025 António Champalimaud Vision Award
Valued at €1 million, it is the world's largest award in the field of vision, recognising work that combines scientific excellence, global impact, and a commitment to equity in eyesight. The Fred Hollows Foundation has restored sight to more than 3 million people in more than 25 countries across Asia, Africa, and Oceania. The Lions Clubs International Foundation (LCIF)...
C-Ray Therapeutics Supports Mednovo’s Phase III Clinical Trial with First Patient Dosed for Lutetium [177Lu] Oxodotreotide Injection
CHENGDU, China, Sept. 10, 2025 /PRNewswire/ -- August 22, 2025, Mednovo Group Co., Ltd. ("Mednovo") announced that the first patient has been successfully dosed in its Phase III clinical trial of Lutetium Oxodotreotide Injection, a Class 3 targeted radiotherapeutic drug. As the exclusive clinical supply and manufacturing partner, C-Ray Therapeutics delivered end-to-end support for this milestone, including technology...
Shineco Achieves Mass Production of High-Purity Physical Phospholipids, Breaking Foreign Monopoly and Unlocking Innovation Across Industries
BEIJING, Sept. 10, 2025 /PRNewswire/ -- Shineco Inc. (NASDAQ: SISI) ("Shineco" or the "Company"), a leading developer of induced pluripotent stem cell (iPSC) technology platforms, today announced that its subsidiary, Fuzhou Meidashan Biotechnology Co., Ltd., has successfully achieved large-scale production of high-purity, highly active free-form soybean phospholipids. This breakthrough was made possible through its proprietary APCC-UF pure physical extraction technology,...
Imaging Endpoints Announces Patent Application for AI Review Charter System
SCOTTSDALE, Ariz., Sept. 10, 2025 /PRNewswire/ -- Imaging Endpoints (IE), the global leader in Imaging CRO technologies and services for oncology trials, announced the filing of a provisional patent application for its revolutionary AI enhanced Imaging Review Charter (IRC) system. This innovative AIRC System™ is designed to enhance highly customized IRCs for clinical...
LakeShore Biopharma Announces Appointment of Independent Financial Advisor and Legal Counsel to the Special Committee
BEIJING, Sept. 10, 2025 /PRNewswire/ -- LakeShore Biopharma Co., Ltd (Nasdaq: LSB, "LakeShore Biopharma" or the "Company"), a global biopharmaceutical company dedicated to discovering, developing, manufacturing, and delivering new generations of vaccines and therapeutic biologics for infectious diseases and cancer, today announced that the independent special committee (the "Special Committee") of the Company's board of directors (the "Board"),...
Optain Health Closes $26 Million Series A to Bring Oculomics to Primary Care and Beyond
Insight Partners leads; seven major U.S. health systems join. Funding accelerates the global rollout of Optain's advanced robotic retinal imaging, AI, and teleophthalmology platform. NEW YORK, Sept. 10, 2025 /PRNewswire/ -- Optain Health, a healthcare technology company applying artificial intelligence (AI), robotic retinal imaging, and teleophthalmology to detect eye and systemic disease...
New Public Perception Survey Highlights Fragmented Cancer Care Pathway in the Philippines; Optimism About Digital Innovations
YouGov survey finds strong belief in value of early detection (76%) but low screening uptake (13%) Confidence in coordinated care (34%) and in 'one-stop' care (36%) among the lowest in Southeast Asia Strongest regional demand for advanced technology in follow-up care and recurrence detection (58%) MANILA, Philippines, Sept. 10, 2025...
